DM

Durairaj Madhumathi

Director Director DIN 08522210
DIN 08522210 First appointment Jul 2019 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jul 2019
Shareholding value Locked Premium profile

About Durairaj Madhumathi

Durairaj Madhumathi has 6 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

DIN 08522210
Primary Designation Director
First Appointment 29 Jul 2019
Oldest Company Age 10 yrs

Current companies

No current companies available.

Previous companies

Company Designation Appointment Founded Status
Grensyn Pharmaceutique Private Limited U24232TN2016PTC104103
Director 29 Jul 2019 2016 Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Grensyn Pharmaceutique Private Limited
Premium access

Shareholding and investment profile for Durairaj Madhumathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Durairaj Madhumathi

Durairaj Madhumathi has 6 years in corporate governance. Holds Director role. Formerly with 1 company. Engaged in General Business. Contributes to corporate operations.

Durairaj Madhumathi is associated with 0 companies as Director.

Durairaj Madhumathi has expertise in General Business.

Durairaj Madhumathi has 6 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available